ADCP Assays

The ADCP assay (Antibody-Dependent Cellular Phagocytosis assay) is a crucial method for evaluating the efficacy of therapeutic antibodies by measuring their ability to promote phagocytosis. This assay plays a significant role in immuno-oncology and infectious disease research, providing insights into how antibodies enhance immune responses. By optimizing the ADCP assay conditions, researchers can achieve more accurate and reproducible results, leading to better therapeutic developments. Whether assessing monoclonal antibodies or vaccine-induced immune responses, the ADCP assay is an essential tool in immunological studies.